Accelovance's deep therapeutic experience within oncology, vaccines, and general medicine provides skilled oversight and program management through the entire clinical development lifecycle — IND submission to NDA approval. Our seasoned professionals have relevant scientific, therapeutic, and operational expertise and will work with you throughout all stages of the trial lifecycle to ensure delivery of consistent, high-quality results.
Find out more about Accelovance's therapeutic expertise in
- Oncology - In addition to Phase 1 - IV oncology program expertise, the HERO Initiative by Accelovance is a specialized program dedicated to accelerating early phase oncology clinical testing. Discover more about our experience with cancer therapies.
- Vaccines & Immunology - Accelovance is an award-winning vaccine CRO, with vast experience managing immunolgy clinical research programs. Learn more about our strong background across many vaccine types, patient populations, and routes of administration.
- General Medicine - Accelovance provides full-service support of Phase I-IV clinical research programs in dermatology, women's health, nutrition, and pain. Read more about the strategic planning that goes into each clinical trial.